Bristol-Myers Squibb
BMY
BMY
1,775 hedge funds and large institutions have $60.3B invested in Bristol-Myers Squibb in 2019 Q2 according to their latest regulatory filings, with 128 funds opening new positions, 728 increasing their positions, 710 reducing their positions, and 135 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,775
Holders Change
-36
Holders Change %
-1.99%
% of All Funds
38.61%
Holding in Top 10
38
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-9.52%
% of All Funds
0.83%
New
128
Increased
728
Reduced
710
Closed
135
Calls
$1.24B
Puts
$1.33B
Net Calls
-$90.8M
Net Calls Change
-$588M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$545M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$431M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
+$423M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$408M |
| 5 |
Renaissance Technologies
New York
|
+$379M |
